[go: up one dir, main page]

MEP17008A - Oksidekahidronaftalen modulatori hm74 - Google Patents

Oksidekahidronaftalen modulatori hm74

Info

Publication number
MEP17008A
MEP17008A MEP-170/08A MEP17008A MEP17008A ME P17008 A MEP17008 A ME P17008A ME P17008 A MEP17008 A ME P17008A ME P17008 A MEP17008 A ME P17008A
Authority
ME
Montenegro
Prior art keywords
oxidekahidron
modulatori
agreement
oxididealin
molecules
Prior art date
Application number
MEP-170/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Anne Minnich
Theresa Kuntzweiler
Haifeng Eishingdrelo
Michael Angelastro
Stephan Henke
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of MEP17008A publication Critical patent/MEP17008A/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MEP-170/08A 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74 MEP17008A (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
RSP-2006/0472A RS20060472A (sr) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (1)

Publication Number Publication Date
MEP17008A true MEP17008A (hr) 2010-06-10

Family

ID=34910747

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2008-170A ME00059B (me) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74
MEP-170/08A MEP17008A (hr) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-2008-170A ME00059B (me) 2004-02-20 2005-02-10 Oksidekahidronaftalen modulatori hm74

Country Status (21)

Country Link
US (2) US7264937B2 (hr)
EP (1) EP1718293A1 (hr)
JP (1) JP2007526917A (hr)
KR (1) KR101145693B1 (hr)
CN (1) CN1929833A (hr)
AR (1) AR047708A1 (hr)
AU (1) AU2005216878B2 (hr)
BR (1) BRPI0507916A (hr)
CA (1) CA2556757C (hr)
CR (1) CR8537A (hr)
EC (1) ECSP066776A (hr)
IL (1) IL177106A (hr)
MA (1) MA28368A1 (hr)
ME (2) ME00059B (hr)
NO (1) NO20064214L (hr)
RS (1) RS20060472A (hr)
RU (1) RU2006133539A (hr)
TN (1) TNSN06235A1 (hr)
TW (1) TWI354552B (hr)
WO (1) WO2005082352A1 (hr)
ZA (1) ZA200606687B (hr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
CA2589483C (en) 2004-12-03 2013-10-29 Schering Corporation Substituted piperazines as cb1 antagonists
NZ569814A (en) * 2006-01-18 2011-10-28 Schering Corp Cannibinoid receptor modulators
US20100197564A1 (en) * 2007-04-19 2010-08-05 Schering Corporation Diaryl morpholines as cb1 modulators
EP2548874A3 (en) * 2007-06-28 2013-05-15 Intervet International B.V. Substituted piperazines as CB1 antagonists
CN101790521A (zh) * 2007-06-28 2010-07-28 英特维特国际股份有限公司 作为cb1拮抗剂的取代哌嗪

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
JP2002508660A (ja) * 1997-06-12 2002-03-19 スミスクライン ビーチャム コーポレーション Hm74a受容体
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
RU2006133539A (ru) 2008-03-27
CR8537A (es) 2007-03-05
ECSP066776A (es) 2006-11-16
WO2005082352A1 (en) 2005-09-09
MA28368A1 (fr) 2006-12-01
IL177106A0 (en) 2006-12-10
CA2556757C (en) 2011-05-03
ME00059B (me) 2010-06-10
AU2005216878B2 (en) 2010-06-17
RS20060472A (sr) 2008-11-28
BRPI0507916A (pt) 2007-07-10
KR101145693B1 (ko) 2012-05-25
TNSN06235A1 (en) 2007-12-03
AR047708A1 (es) 2006-02-08
EP1718293A1 (en) 2006-11-08
ZA200606687B (en) 2008-02-27
CN1929833A (zh) 2007-03-14
KR20060127982A (ko) 2006-12-13
US20050187263A1 (en) 2005-08-25
TW200539864A (en) 2005-12-16
JP2007526917A (ja) 2007-09-20
CA2556757A1 (en) 2005-09-09
TWI354552B (en) 2011-12-21
US7264937B2 (en) 2007-09-04
AU2005216878A1 (en) 2005-09-09
US20080045586A1 (en) 2008-02-21
NO20064214L (no) 2006-09-18
IL177106A (en) 2012-03-29

Similar Documents

Publication Publication Date Title
EA201100875A1 (ru) Новые пиразол-4-n-алкоксикарбоксамиды в качестве микробиоцидов
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA201100125A1 (ru) Производные пирролопиридинилпиримидин-2-иламина
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
GT200600112A (es) Composiciiones de tigeciclina y metodos de preparacion
ATE508190T1 (de) Mehrfachpromotor-expressionskassetten zurgleichzeitigen zuführung von rnai-agentien
EA201000549A1 (ru) Производные пиперидина и пиперазина
EA201001456A1 (ru) Новые гетероциклические соединения и их применение
MX2020003168A (es) Pirimidinas modificadas en la posicion 5 y su uso.
EA200701771A1 (ru) Низкомолекулярные ингибиторы mdm2 и их применение
GB2436983A (en) Information access with usage-driven metadata feedback
BRPI0615705A2 (pt) processo para preparar um composto, e, composto
ATE517874T1 (de) Pyrimidinone als modulatoren von caseinkinase ii (ck2)
EA201070519A1 (ru) Соединения тропана
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
EA201170132A1 (ru) 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов
EA201070410A1 (ru) Твердые формы (s)-этил-2-амино-3-(4-(2-амино-6-((r)-1-(4-хлор-2-(3-метил-1h-пиразол-1-ил)фенил)-2,2,2-трифторэтокси)пиримидин-4-ил)фенил)пропаноата и способы их применения
BRPI0606112A2 (pt) 3 - heteroaril - 3 - hidróxi - 2 - amino - propil aminas e compostos relacionados, bem como uso dos mesmos e composição farmacêutica
EA201000550A1 (ru) Производные тиазола
EA200700537A1 (ru) Триазолофталазины
UA106880C2 (uk) Нові гербіциди
MA32818B1 (fr) Arylpiperazines et leur emploi en tant qu'antagonistes de alpha2c
EA201101097A1 (ru) Новые микробиоциды
NO20081207L (no) Isoquinolines as IGF-1R inhibitors
MEP17008A (hr) Oksidekahidronaftalen modulatori hm74